Artificial Salt Veterinary Grade API is a purified multi-electrolyte crystalline matrix supplied as three model-designated particle-size grades: ASV-VG-7.0 for direct compression of oral tablets and hard capsules, ASV-VG-7.2 for injectable solutions and sterile powders, and ASV-VG-7.4 for oral powders and veterinary premixes. The API contains sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, and sodium bicarbonate in a controlled ratio that permits the manufacture of Ringer-type isotonic vehicles, oral rehydration salts, and mineral supplement boluses. The manufacturing route follows EU GMP Part II and a VICH-compliant master file, with release testing performed against Ph.Eur. and USP methods. This grade is not commodity sodium chloride because the cation and anion concentrations are controlled by ion chromatography with conductivity detection and by complexometric titration rather than by chloride assay alone. For injection-grade ASV-VG-7.2, bacterial endotoxin limits, particulate matter counts, and sterility testing are applied as mandatory release tests. The material is supplied without flow agents, anti-caking agents, or preserving agents. Excipient selection is the responsibility of the dosage-form manufacturer, but the API is released with residue on ignition, loss on drying, and ionic assay data sufficient for formulation calculations without unaccounted mass loss.

What Distinguishes This API from Feed-Grade and Reagent-Grade Electrolyte Mixtures?

Feed-grade sodium chloride and reagent-grade sodium chloride are not interchangeable with this API in injectable or oral rehydration formulations. Feed-grade salt is not typically tested for bacterial endotoxins according to USP <85>, and its heavy metal burden may be insufficiently controlled for parenteral exposure. Reagent-grade ACS sodium chloride may contain lower impurities but does not carry the particle-size control, endotoxin release, or batch-to-batch ion ratio validation required for veterinary drug product filing. Food-grade salt often contains sodium ferrocyanide E535 or sodium aluminosilicate as anti-caking agents; these substances are not declared through quantitative cation-anion assay and can interfere with redox-sensitive actives or alter dissolution pH. The present API is released with pH of a 1% aqueous solution controlled to 5.0–7.5, and the injection grade is controlled to ≤ 2.5 EU/g by USP <85>; feed- and food-grade products generally have no defined endotoxin acceptance criterion. The multi-ion content is also not conventional table salt. Calcium, magnesium, acetate, and bicarbonate fractions support tonicity adjustment and acid-base balance; without them, a sodium chloride-only solution produces hyperchloremic acidosis at high-volume infusion and lacks the physiological cation complement expected in Ringer-type veterinary fluids. Technical-grade evaporator salt is not suitable because it can carry bromide, sulfate, nitrate, and anti-caking residues, and it lacks a documented manufacturing history required under EU GMP Part II.

Pharmacopoeial Specification Matrix and the Role of Endotoxin Control

Release of the parenteral grade includes a compendial specification matrix covering identity, assay, loss on drying, impurity elements, endotoxins, particulate matter, and sterility. The non-sterile powder grades are released with microbial limits per USP <61> and USP <62>. Table 1 lists the release criteria.

The three model-designated grade differentiations are summarized in Table 2. The particle-size window is intended to match the processing route and not to act as a blend of unknown excipients.

In direct compression on a 12-station B-tooling rotary press with 8 mm flat-faced bevel-edge punches, ASV-VG-7.0 was dry-blended with microcrystalline cellulose 102, pregelatinized starch, 2.5% w/w crospovidone, and 0.6% w/w magnesium stearate. The blend had a Carr index of 21%, which required force feeder operation at 25 rpm to maintain weight variation below 1.0%. Main compression force was set at 12–18 kN; tablet hardness fell below 4 N when blend moisture exceeded 1.2%, and capping occurred above 18 kN when residual moisture was below 0.3%. Tablets were compacted to a thickness of 3.2–3.6 mm and then film-coated with an aqueous hydroxypropyl methylcellulose system; coating pan inlet air temperature was 65°C and exhaust temperature 42°C because the core contains heat-labile bicarbonate. No anti-caking agent was required if the drum was used within 30 min of discharge.

For the parenteral grade ASV-VG-7.2, dissolution in water for injection at 25–30°C under a nitrogen overlay produced a clear solution at 0.9% w/v within 4 min using a bottom-mounted magnetic impeller at 120 rpm. The batch was filtered through a 0.22 µm polyvinylidene fluoride membrane preceded by a 0.45 µm polyethersulfone prefilter; transmembrane pressure was maintained below 1.0 bar. Terminal heat sterilization of bicarbonate-containing solutions requires headspace venting or a CO₂-stripping procedure because sealed-container autoclaving at 121°C for 15 min shifts carbonate equilibrium and can raise pH above 8.2. The solution is compatible with polypropylene and glass type II containers; it is not stored in uncoated type I glass with elevated calcium and magnesium at pH above 7.0 due to surface deposition after long-term storage.

Granulation of the same API in a high-shear granulator with a 300 L bowl and 4.0 m/s impeller tip speed required water addition of 8–10% w/w. When magnesium chloride hexahydrate content was above 2.5% w/w, the wet mass temperature increased from 22°C to 28°C within 2 min due to exothermic hydration; chopper speed was reduced to 1200 rpm to avoid overwetting. Drying in a fluid-bed dryer with inlet air at 60°C and an end-point LOD of 1.0–1.5% w/w produced granules with bulk tapped density 0.72 g/cm³ and Hausner ratio 1.18, suitable for capsule filling. Granules with an LOD above 2.0% w/w stored in low-density polyethylene bags for more than 24 h showed bead hardening and dissolution slowdown in 0.1 M hydrochloric acid, attributed to surface recrystallization of calcium chloride.

Oral powder and premix use of ASV-VG-7.4 in a horizontal ribbon mixer with 500 kg capacity and 12 rpm achieved a coefficient of variation of 2.8% for chloride after 10 min of mixing with a limestone carrier. The larger particle-size cut reduces dust generation; measured dustiness by an SP3 dustiness tester was 4.2 mg/kg. Water-soluble sachets made from ASV-VG-7.4 dissolved within 60 s in 250 mL of water at 20°C when the granulation was formulated with citric acid and sodium carbonate as effervescent partners; however, the bicarbonate content of the API must be accounted for because it contributes to carbon dioxide release and may cause sachet bloating if residual moisture exceeds 0.4% w/w.

When Injectable Solutions Require Osmolarity Adjustment Without Extraneous Sodium

Formulation of a balanced veterinary maintenance electrolyte solution requires adjustment of osmolarity and chloride load without relying solely on sodium chloride. The acetate and bicarbonate fractions in the API function as alkalinizing anions and reduce the chloride load compared with 0.9% saline, which carries 154 mmol/L sodium and 154 mmol/L chloride. In a typical 0.9% w/v reconstituted solution of ASV-VG-7.2, measured osmolarity by freezing-point depression is 280–300 mOsmol/kg, not the 308 mOsmol/kg of sodium chloride 0.9% injection. The difference allows the formulator to increase sodium chloride or potassium chloride to meet species-specific electrolyte demands without exceeding the 350 mOsmol/kg upper limit for peripheral intravenous administration in cattle. Calcium and magnesium concentrations must remain below 0.02% w/v and 0.01% w/v, respectively, if phosphate, citrate, or bicarbonate-containing additives are introduced; otherwise calcium phosphate or magnesium carbonate precipitate occurs above pH 6.5. Fluid compatibility testing should include a 24 h visual inspection with scattered-light particulate measurement under an obscuration threshold of > 5 µm particle diameter per USP <788>.

Direct Compression Grades Require a Narrow Particle-Size Fraction

A narrow particle-size distribution is the primary process variable for tablet and capsule weight uniformity. The ASV-VG-7.0 grade is controlled at D50 130–180 µm, with D10 no less than 50 µm and D90 no greater than 250 µm by laser diffraction. Bulk density is 1.06 g/cm³; tapped density is 1.32 g/cm³; the resulting Carr index is 20% and Hausner ratio is 1.24, which requires forced feeder assistance but avoids overgranulation and allows use of 15% w/w microcrystalline cellulose as a dry binder. Milling through a 0.5 mm screen with a rotor speed of 3000 rpm is acceptable for de-agglomeration, but milling below 0.3 mm reduces compressibility because the API has a needle-like crystalline aspect ratio and undergoes plastic deformation under compaction. Tablet press speed above 60 rpm on a B-tooling press requires punch lubrication with magnesium stearate; addition above 0.8% w/w prolongs disintegration beyond 15 min in water at 37°C because hydrophobic stearate films reduce water penetration into the porous salt matrix.

Evaluating Dissolution and Content Uniformity Across Mixed-Salt Granules

Dissolution testing in pH 2.0 hydrochloric acid medium (0.01 M) with paddle speed 50 rpm shows release of sodium, potassium, and chloride from compressed tablets within 15 min, while calcium and magnesium release reaches 85% within 30 min. Content uniformity of 10 dosage units is evaluated according to USP <905>; the ionic matrix creates a high-density bias during blend handling, and static charge separation was observed when conveying the dry blend through a 2 m polyethylene tube at 8 kg/h. Grounding the discharge and maintaining 40% relative humidity during capsule filling suppressed static separation. During stability storage at 40°C/75% RH in aluminium foil pouches for 6 months, sodium chloride assay remained within 98.0–102.0%, but loss on drying increased from 0.3% to 0.6% w/w in a low-density polyethylene bag, indicating that only foil or foil-laminated overwrap is suitable for ASV-VG-7.0 and ASV-VG-7.2.